Cullinan Oncology, Inc. (CGEM) Tops Q1 EPS by 8c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q1 EPS of ($0.74), $0.08 better than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Bessent: U.S. will enforce 'zero leakage' approach to Iran sanctions
• Freedom Broker Starts Citizens Inc. (CIA) at Buy
• U.S. Treasury sanctions nearly 60 Iran-linked entities, people and vessels across nuclear, missile, cyber and oil networks